PTK2 and neoplasm: We found that CCL22 increased the phosphorylation of various intratumoral signaling substrates, especially FAK, the crucial hub that transduces tumor microenvironmental signals into tumor cells [30, 48, 49] and regulates multiple malignant phenotypes during tumor progression.